ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,986Medicare Part D Prescriptions Filled, Including Refills

Rank: 12 out of 1692

$1.51M Total Retail Price of All Prescriptions

Rank: 10 out of 1692

887 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
54% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 887 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

28% of this provider’s 887 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 17,617 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
HYDROCODONE-ACETAMINOPHEN 1,683 1,048 S3 1 6
AMLODIPINE BESYLATE 883 747 2 3
SIMVASTATIN 815 633 3 1
OMEPRAZOLE 677 440 4 5
LEVOTHYROXINE SODIUM 632 469 5 4
LISINOPRIL 612 473 6 2
METFORMIN HCL 494 378 7 8
FUROSEMIDE 466 365 8 7
GABAPENTIN 433 312 9 13
ATENOLOL 341 284 10 15
PRAVASTATIN SODIUM 314 263 11 12
POTASSIUM CHLORIDE 309 249 12 20
NAMENDA 287 275 13 50
TRAZODONE HCL 282 167 14 33
DONEPEZIL HCL 277 272 15 29
RANITIDINE HCL 271 193 16 28
SERTRALINE HCL 253 156 17 22
NEXIUM 251 203 18 25
CITALOPRAM HBR 250 215 19 21
ATORVASTATIN CALCIUM 242 180 20 11
FLUOXETINE HCL 230 144 21 52
CARVEDILOL 226 218 22 24
METOPROLOL TARTRATE 218 191 23 10
HYDROCHLOROTHIAZIDE 213 184 24 9
TRAMADOL HCL 198 175 25 16
SYNTHROID 191 160 26 59
AMLODIPINE BESYLATE-BENAZEPRIL 190 151 27 67
ZOLPIDEM TARTRATE 188 107 28 23
LOSARTAN-HYDROCHLOROTHIAZIDE 179 167 29 38
LOSARTAN POTASSIUM 177 168 30 17
PREDNISONE 173 148 31 35
METHADONE HCL 173 53 S2 31 135
LISINOPRIL-HYDROCHLOROTHIAZIDE 151 129 33 19
CYMBALTA 150 83 34 51
ALLOPURINOL 145 109 35 30
ATENOLOL-CHLORTHALIDONE 144 115 36 156
ESCITALOPRAM OXALATE 143 119 37 76
ALPRAZOLAM 138 123 38 188
GLIPIZIDE 137 98 39 47
AZITHROMYCIN 133 89 40 34
FLUTICASONE PROPIONATE 133 69 40 27
DIOVAN 132 120 42 42
ISOSORBIDE MONONITRATE ER 127 108 43 55
CLOPIDOGREL 125 93 44 43
EXELON 121 109 45 187
PAROXETINE HCL 116 67 46 60
TRIAMTERENE-HYDROCHLOROTHIAZID 116 104 46 214
AMITRIPTYLINE HCL 115 57 R 48 58
WARFARIN SODIUM 110 99 49 14
PLAVIX 110 93 49 66
PANTOPRAZOLE SODIUM 109 74 51 39
CIPROFLOXACIN HCL 107 85 52 65
PROAIR HFA 105 76 53 40
DIGOXIN 101 101 54 85
GEMFIBROZIL 101 58 54 98
CARBIDOPA-LEVODOPA 100 87 56 110
METOPROLOL SUCCINATE 98 84 57 18
RISPERIDONE 95 65 58 77
LANTUS SOLOSTAR 94 55 59 102
OXYCODONE HCL 93 25 S2 60 56
SINGULAIR 89 71 61 79
MIRTAZAPINE 88 88 62 53
AMOXICILLIN 88 64 62 95
MORPHINE SULFATE ER 88 31 S2 62 121
LANTUS 87 45 65 57
VERAPAMIL ER 87 86 65 90
ESTRADIOL 87 17 R 65 227
ADVAIR DISKUS 86 44 68 45
BYSTOLIC 85 69 69 129
PROMETHAZINE HCL 85 44 R 69 81
SPIRONOLACTONE 84 64 71 74
ROPINIROLE HCL 84 40 71 101
ABILIFY 84 25 71 194
TRIAMCINOLONE ACETONIDE 83 59 74 105
OXYCODONE HCL-ACETAMINOPHEN 82 30 S2 75 94
MEGESTROL ACETATE 82 76 R 75 185
VENLAFAXINE HCL ER 81 50 77 84
OXYBUTYNIN CHLORIDE ER 75 61 78 152
DICYCLOMINE HCL 72 36 79 259
BENAZEPRIL HCL 72 72 79 69
CLONIDINE HCL 71 57 81 46
CEPHALEXIN 71 55 81 89
LIPITOR 71 47 81 119
CRESTOR 70 57 84 26
QUETIAPINE FUMARATE 69 59 85 62
LYRICA 68 43 86 111
METOCLOPRAMIDE HCL 68 47 86 146
DIVALPROEX SODIUM ER 68 54 86 212
PROPRANOLOL HCL 68 51 86 109
LEXAPRO 67 50 90 240
SULFAMETHOXAZOLE-TRIMETHOPRIM 67 31 90 100
IBUPROFEN 66 32 92 78
METOLAZONE 64 43 93 224
CYCLOBENZAPRINE HCL 63 24 R 94 54
GLIMEPIRIDE 63 45 94 32
FENTANYL 63 53 S2 94 88
SPIRIVA 63 41 94 44
NOVOLOG MIX 70-30 FLEXPEN 62 39 98 312
OXYBUTYNIN CHLORIDE 60 59 99 162
TIZANIDINE HCL 60 19 99 127
JANUVIA 60 38 99 72
GLYBURIDE-METFORMIN HCL 60 30 R 99 157
OXYCODONE-ACETAMINOPHEN 58 38 S2 103 70
MELOXICAM 57 24 104 41
LEVOXYL 57 44 104 170
MONTELUKAST SODIUM 56 43 106 144
POLYETHYLENE GLYCOL 3350 56 28 106 64
QUINAPRIL HCL 56 49 106 147
DIOVAN HCT 56 56 106 73
LIDODERM 56 44 106 138
DOXEPIN HCL 55 23 111 204
NITROFURANTOIN 54 54 112 279
EVISTA 53 52 113 140
KLOR-CON M20 51 36 114 48
NIASPAN 51 29 114 123
CEFDINIR 50 37 116 183
IPRATROPIUM-ALBUTEROL 50 50 116 155
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 8, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.